Cintas (CTAS) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
7 Oct, 2026Executive summary
Record Q1 revenue of $3.014B, up 10.9% year over year; organic revenue growth was 8.9%.
Net income rose 12.3% to $551.7M; diluted EPS increased 13.3% to $1.36, or $1.39 adjusted for UniFirst transaction costs.
Operating income grew 15.2% to $711.9M; operating margin reached 23.6%, up from 22.7%.
Fiscal 2027 revenue and adjusted diluted EPS guidance were raised to $12.15–$12.27B and $5.45–$5.54, respectively.
Financial highlights
Gross margin was $1.55B, or 51.5% of revenue, up 120 basis points year over year; selling and administrative expense improved to 27.4% of revenue.
Operating income was $711.9M versus $617.9M; adjusted operating income increased 17.6%.
Free cash flow was $464.8M, versus $312.5M a year earlier; operating cash flow was $572.3M.
Effective tax rate was 20.0%, versus 17.6%; both periods were affected by discrete items, primarily stock-based compensation tax accounting.
Outlook and guidance
FY27 revenue guidance: $12.15–$12.27B, representing 7.9%–8.9% growth; adjusted diluted EPS guidance: $5.45–$5.54, representing 10.3%–12.1% growth.
Guidance excludes the proposed UniFirst acquisition and assumes constant FX rates; no future acquisitions are included.
FY27 effective tax rate is expected to be 20.4%; incremental margins are expected at 32%–34%.
UniFirst closing is expected before calendar year-end 2026, subject to customary conditions and FTC review; closing is barred before December 11 absent earlier FTC clearance.
Latest events from Cintas
- Board and governance votes passed, while the majority-vote proposal failed; UniFirst review continues.CTAS
AGM 2026 - Agenda paired three supermajority-rule amendments with board opposition to two shareholder proposals.CTAS
Proxy Filing - Board backed all director nominees and annual pay votes, but opposed DEI and climate proposals.CTAS
Proxy Filing - Board backed nominees, pay, equity plan, and auditor; opposed three disclosure proposals.CTAS
Proxy Filing - Board backs all nominees, pay, and auditor; opposes the special-meeting proposal.CTAS
Proxy Filing - Record growth, strategic investments, and key governance changes headline this year's proxy.CTAS
Proxy filing - Virtual annual meeting to vote on directors, pay, auditor, reincorporation, and governance.CTAS
Proxy filing - Record growth, Delaware reincorporation, and strong governance highlight this year's proxy.CTAS
Proxy filing - Record revenue and margin growth in 2026; strong 2027 outlook with continued investment.CTAS
Q4 2026